In urothelial carcinoma, colorectal cancer, and acute myeloid leukemia, KMT2C has been shown to function as a tumor suppressor, although its role in tumorigenesis remains largely uncertain [32,80,110,111,112]. This evidence concerns the gene KMT2C and neoplasm.